The Thing I Noticed
Three years ago, if someone at a dinner party mentioned taking Ozempic for weight loss, the conversation would stop. There would be that specific kind of silence where everyone becomes very interested in their appetizer. Now? People talk about it the way they talk about their antidepressants or their sleep struggles. Matter-of-fact. A little tired of the whole thing, honestly.
By the end of 2025, about nine million Americans had active prescriptions for GLP-1 receptor agonists like semaglutide or tirzepatide. That number alone tells you something has shifted. But the statistic that actually stuck with me came from a YouGov poll: in October 2025, 31% of American adults said they personally knew someone taking one of these drugs. Two years earlier, it was 12%. We went from knowing one person who might be taking it to knowing three. That’s not a trend line. That’s your actual life changing.
I’ve been thinking about what that shift means beyond the prescriptions and the revenue numbers. Because this isn’t really a story about drugs. It’s a story about what happens when medical science makes something undeniable.
When The Numbers Become Impossible To Ignore
Let’s start with what these drugs actually do, because the clinical data is genuinely remarkable. A recent New England Journal of Medicine obesity drug trials showed that tirzepatide produced an average weight loss of 22.5% of body weight over 72 weeks in people with obesity. That’s the highest average documented for any approved drug, ever. Eli Lilly reported that Zepbound alone generated $4.9 billion in revenue year-to-date by Q3 2025, making it one of the fastest-growing pharmaceutical products in history.
But here’s what I find more interesting than the numbers themselves: what those numbers forced into the room. For decades, the conversation around weight loss was built on a very specific foundation. Eat less. Move more. Have more willpower. If you’re struggling, it’s because you’re not trying hard enough. It was simple. It was tidy. And it was wrong in a way that made a lot of people feel like failures.
Then came drugs that worked consistently and significantly, and suddenly the entire framing fell apart. You can’t tell someone their weight is a willpower problem when they’re losing a quarter of their body weight while taking a medication. You can’t keep pretending that obesity is purely behavioral when the science shows it involves complex hormonal and neurological factors that a small injection can influence.
The Quiet Revolution In How We Talk About Bodies
According to NPR coverage of GLP-1 drugs and weight stigma, registered dietitian and researcher Dr. Fatima Cody Stanford noted that the cultural acceptance of these medications was helping to dismantle the long-held belief that obesity is purely a willpower issue. What struck me about that observation is how it acknowledges something that wasn’t explicitly being said before: we’ve been operating on a false premise.
For a long time, weight loss was positioned as a personal moral achievement. You succeeded or you failed. You had discipline or you didn’t. It was individualistic in a way that felt righteous but also cruel, because it meant that if you were struggling, the problem was internal. Something was wrong with you.
Now there’s a drug that works regardless of your discipline, and that changes the entire story. It’s not that willpower doesn’t matter anymore. It’s that we have to finally acknowledge what researchers have known for years: willpower exists in a body, and that body has its own logic. Hunger signals, metabolic set points, hormonal systems that can work against you no matter how determined you are.
What Happens When Treatment Becomes Mainstream
The thing about something becoming normal is that it forces a reckoning. Nine million prescriptions means these drugs are in suburban living rooms and city apartments and small towns. They’re with people who can afford them and people who can’t, who are navigating insurance denials and side effects and the weird experience of not thinking about food the way they used to.
It also means we have to stop treating weight loss as either a moral victory or a moral failing and start treating it as what it actually is: a medical intervention. Like most medical interventions, it works for some people and not others. It has side effects. It’s a tool, not a personality trait.
I think about the dinner party scenario again, the one where people now talk about their GLP-1 prescriptions the way they talk about other medications. What that signals is permission. Permission to say that your body doesn’t respond the way you thought it should. Permission to try something that feels different or strange or like you’re taking a shortcut. Permission, maybe, to stop performing the struggle.
The Conversation That’s Still Unfinished
Here’s what I don’t think we’ve figured out yet: what comes after the cultural acceptance. The drugs are mainstream now, but we’re still sorting through what that means. Questions about access, about long-term use, about what happens when you stop, about the difference between weight loss and health, about how we talk to people who lose weight through medication versus other means.
We’re also still working through the identity question. For people who spent years or decades thinking about weight as a personal project, as something they carried with them and struggled against, the idea of a medication handling it can feel strange. There’s relief, sure. But there’s also something else. A kind of vertigo about who you are if you’re not managing that anymore.
What I find most interesting about this moment is that we’re finally having to talk about weight honestly. Not as a referendum on character. Not as something that exists in a vacuum. But as something embedded in bodies that are complicated and systems that are bigger than individual choices. The drugs didn’t create that truth. They just made it impossible to keep ignoring.
What’s your experience been with this shift? Have you noticed the conversation changing around you, or have you found yourself part of it in ways you didn’t expect? I’d love to hear what you’re thinking about all of this.